Lansoprazole Capsule, Delayed Release
Product Images NDC 71335-0058

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-0058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph depicting the mean severity of day heartburn over days from the start of treatment for evaluable patients, comparing placebo, lansoprazole 15 mg, and lansoprazole 30 mg. Severity is rated from 0 (none) to 3 (severe). Lansoprazole treatments show a decline in heartburn severity over time compared to placebo.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph depicting the mean severity of night heartburn over time for patients in a study, comparing placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. The y-axis represents mean severity from 0 (none) to 3 (severe), and the x-axis shows days from the start of treatment up to 60 days.*
FDA Label Image

Label Image (Lbl713350058)

Label Image (Lbl713350058)
Lansoprazole DR 15 mg capsule label from Bryant Ranch Prepack, indicating delayed release capsules with a pink/green color. The label notes it is comparable to Prevacid 15 mg capsules by Dr. Reddy's Laboratories. It contains 30 capsules, with storage instructions to keep tightly closed at room temperature (20°-25°C/68°-77°F) and keep out of reach of children. The product is RX only and includes the NDC 71335-0058-81.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lansoprazole, displaying its molecular components including indazole, sulfoxide, and substituted pyridine rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.